Literature DB >> 5429182

The role of plasma protein binding in the inhibitory effect of nortriptyline on the neuronal uptake of norepinephrine.

O Borgå, B Hamberger, T Malmfors, F Sjöqvist.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5429182     DOI: 10.1002/cpt1970114581

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

1.  Effects of chlorpromazine, thioridazine and haloperidol on adrenergic transmitter mechanisms in man.

Authors:  J R Tuck
Journal:  Eur J Clin Pharmacol       Date:  1973-08       Impact factor: 2.953

2.  Bicarbonate therapy for dysrhythmia and hypotension in tricyclic antidepressant overdose.

Authors:  J R Hoffman; C R McElroy
Journal:  West J Med       Date:  1981-01

3.  Inhibition of 5-hydroxytryptamine and noradrenaline uptake in platelets and synaptosomes incubated in plasma from human subjects treated with amitryptyline or nortriptyline: utilization of the principle for a bioassay method.

Authors:  J Tuomisto; E Tukiainen; R Voutilainen; P Tuomainen
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Inhibition of platelet uptake of serotonin in plasma from patients treated with clomipramine and amitriptyline.

Authors:  O Lingjaerde
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

5.  Renal function, protein binding and pharmacological response to diazoxide.

Authors:  R M Pearson; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

6.  Pharmacokinetics of lofepramine in man: relationship to inhibition of noradrenaline uptake.

Authors:  G P Forshell; B Siwers; J R Tuck
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

7.  Protein binding of anthraquinone glycosides, with special reference to adriamycin.

Authors:  S Eksborg; H Ehrsson; B Ekqvist
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.